LINC00599-MYH9 liquid-liquid phase separation analysis

Exploratory Score: 0.850 Price: $0.50 Pulmonary hypertension In vitro phase separation assays Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting LINC00599 in In vitro phase separation assays. Primary outcome: Liquid-liquid phase separation formation

Description

This mechanistic study investigated the molecular interaction between LINC00599 and MYH9 (myosin heavy chain 9) through liquid-liquid phase separation. The research demonstrated that LINC00599 facilitates liquid-liquid phase separation with MYH9, which is a process previously implicated in cell-cycle regulation. This represents a novel mechanism by which long noncoding RNAs can regulate cellular processes, distinct from traditional RNA-protein interactions. The phase separation mechanism was shown to be critical for LINC00599's role in promoting PASMC proliferation and subsequent pulmonary hypertension progression.

TARGET GENE
LINC00599
MODEL SYSTEM
In vitro phase separation assays
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
Liquid-liquid phase separation and cell cycle regulation
SOURCE
extracted_from_pmid_40693377
PRIMARY OUTCOME
Liquid-liquid phase separation formation

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.850 composite

📖 Wiki Pages

RNA Interference (RNAi) Therapies for NeurodegenertherapeuticRNA-Based Therapeutics for Neurodegenerative DiseatherapeuticRNA Targeting Therapy for NeurodegenerationtherapeuticRNA-Targeting Therapies for Neurodegenerative DisetherapeuticRNA-Based Therapeutics for Alzheimer's DiseasetherapeuticRNA Editing TherapeuticstechnologyRNA Toxicity PathwaymechanismRNA-Targeted Therapeutics Investment SynthesismechanismRNA-Targeted Therapies in NeurodegenerationmechanismRNA Stability and DecaymechanismRNA Splicing Defects in NeurodegenerationmechanismRNA Splicing Dysregulation in 4R-Tauopathies: A ComechanismRNA Splicing in NeurodegenerationmechanismRNA Processing in NeurodegenerationmechanismRNA Metabolism Dysregulation Pathwaymechanism

Protocol

Analysis of LINC00599-MYH9 interaction through liquid-liquid phase separation assays

Expected Outcomes

LINC00599 facilitates phase separation with MYH9 to regulate cell proliferation

Success Criteria

Demonstration of phase separation complex formation between LINC00599 and MYH9

Related Hypotheses (0)

No related hypotheses

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.